Trial NCT01797965

View at ClinicalTrials.gov 
Org. Study IDs: 205MS303
Secondary IDs: 2012-003176-39

Last trial update was posted on 2019-12-04

MeSH Interventions

Daclizumab

MeSH Conditions

Multiple Sclerosis Multiple Sclerosis, Relapsing-Remitting Sclerosis

Other Conditions

Relapsing-Remitting Multiple Sclerosis

Stopping Reasons

Study terminated because of differences in the participant population under study compared with indicated Zinbryta use in most countries.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID